Pharmaceutical Research and Manufacturers of America v. McClain
Petition for certiorari denied on December 9, 2024
Issue: Whether the U.S. Court of Appeals for the 8th Circuit erred in holding that a state may strip manufacturers of the ability preserved to them by the federal 340B Drug Pricing Program to impose conditions on the use of contract pharmacies as part of the offer to provide 340B-priced drugs and intrude on 340B"s centralized enforcement scheme.
SCOTUSblog Coverage
- Western Apache group calls on court to block approval of copper mine on sacred site (Kalvis Golde, November 21, 2024)
| Date | Proceedings and Orders |
|---|---|
| 07/31/2024 | Petition for a writ of certiorari filed. (Response due September 3, 2024) |
| 08/20/2024 | Motion to extend the time to file a response from September 3, 2024 to November 4, 2024, submitted to The Clerk. |
| 08/21/2024 | Motion to extend the time to file a response is granted and the time is extended to and including November 4, 2024. |
| 09/03/2024 | Brief amicus curiae of Kalderos, Inc. filed. |
| 11/04/2024 | Brief of respondents Community Health Centers of Arkansas and Piggott Community Hospital in opposition filed. |
| 11/04/2024 | Brief of respondent Alan McClain, Commissioner of the Arkansas Insurance Department, in opposition filed. |
| 11/19/2024 | DISTRIBUTED for Conference of 12/6/2024. |
| 11/19/2024 | Reply of petitioner Pharmaceutical Research and Manufacturers of America filed. (Distributed) |
| 12/09/2024 | Petition DENIED. |